Y10S 977/912
Cancer cell repair
Y10S977/912 (Cancer cell repair) appears on 31 US grants and 14 published applications in this corpus.
Search patents in Y10S- Granted patents
- 31
- Published applications
- 14
- Assignees
- 24
- Inventors
- 84
- Latest grant
- 19 Aug 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 4 | 0 |
| 1998 | 0 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 4 |
| 2003 | 8 | 1 |
| 2004 | 2 | 3 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 3 |
| 2013 | 0 | 0 |
| 2014 | 3 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Method and composition for hyperthermally treating cells19 Aug 2014US 8,808,268 B2
- Method and composition for hyperthermally treating cells12 Aug 2014US 8,801,690 B2
- Method and composition for hyperthermally treating cells5 Aug 2014US 8,795,251 B2
- Method of inducing apoptosis by reducing the level of thiamin28 Sep 2010US 7,803,531 B2Brandeis University
- Molecules that home to various selected organs or tissues23 Aug 2005US 6,933,281 B2The Burnham Institute
- Method and composition for hyperthermally treating cells11 Oct 2012US 2012/0259205 A1
- Method and composition for hyperthermally treating cells6 Sep 2012US 2012/0226139 A1
- Method and composition for hyperthermally treating cells7 Jun 2012US 2012/0143043 A1
- Devices containing dna encoding neurotrophic agents and related compositions and methods26 Jun 2008US 2008/0152689 A1King's College
- Molecules that home to various selected organs or tissues7 Apr 2005US 2005/0074812 A1The Burnham Institute
Most cited
By later US patents
- Compositions for regeneration and repair of cartilage lesions251US 6,511,958 B1Sulzer Biologics, Inc. · 2003
- Molecules that home to various selected organs or tissues93US 6,232,287 B1The Burnham Institute · 2001
- Treatment of platelet derived growth factor related disorders such as cancers77US 5,700,823 ABiosignal Limited · 1997
- Controlled release of pharmaceutically active substances for immunotherapy66US 5,861,159 AThe Johns Hopkins University School of Medicine · 1999
- Treatment of platelet derived growth factor related disorders such as cancers61US 5,990,141 ASugen, Inc. · 1999